Notch1胞内结构域、P63与c-MYC在泪腺腺样囊性癌中的预后意义
该研究回顾了1998至2018年接受手术的泪腺腺样囊性癌患者,对21例有存档肿瘤组织的标本行免疫组化检测NICD1、c-MYC和P63表达。NICD1阳性与实体型图案、眶内容物剜除、局部复发和死亡相关,且与较差的无病生存期相关(HR 6.27);P63阳性与较好的无病生存期相关(HR 0.03)。作者认为NICD1和P63的免疫组化检测因其预后价值及潜在治疗靶点应被考虑。
要点
- NICD1阳性与实体型图案、眶内容物剜除、局部复发和死亡相关。
- P63阴性表达与实体型图案、局部复发、远处转移和死亡相关。
- NICD1阳性者无病生存期较差(HR 6.27),P63阳性者无病生存期较好(HR 0.03)。
核心结论
- 作者认为,鉴于NICD1和P63的预后价值及作为治疗靶点的潜力,泪腺腺样囊性癌应行NICD1和P63免疫组化检测。
研究设计与样本
- 回顾性分析1998至2018年接受手术的泪腺腺样囊性癌患者记录,收集临床病理和治疗数据,对存档肿瘤组织行光镜和免疫组化检测。
- 研究期间共治疗43例患者,其中21例有存档肿瘤组织可用并纳入分析。
主要发现
- 诊断时中位年龄47岁,13例(62%)为男性;13例(62%)为T2期,诊断时均无淋巴结或远处转移。
- NICD1阳性8例(38%),c-MYC阳性8例(38%),P63阳性11例(52%)。
- NICD1阳性与以实体型(vs.筛状/管状)图案为主(P < 0.001)、接受眶内容物剜除(vs.保留眼球手术)(P = 0.008)、局部复发(P = 0.047)和死亡(P = 0.012)相关。
- P63阴性表达与以实体型图案为主(P = 0.001)、局部复发(P = 0.012)、远处转移(P = 0.001)和死亡(P = 0.035)相关。
- c-MYC染色肿瘤细胞百分比较高与存在神经周围侵犯相关(P = 0.036)。
关键数值与推荐
- NICD1阳性与较差的无病生存期相关(风险比6.27;95%CI 1.29-30.46)。
- P63阳性与较好的无病生存期相关(风险比0.03;95%CI 0.0002-0.26)。
临床怎么用
- 作者认为,泪腺腺样囊性癌应行NICD1和P63免疫组化检测,因其具有预后价值并可能作为治疗靶点。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We assessed whether NICD1 expression, c-MYC expression, and P63 expression by immunohistochemistry (IHC) correlate with prognosis and high-risk clinicopathological features in lacrimal gland adenoid cystic carcinoma (ACC). METHODS: Records of patients with lacrimal gland ACC who underwent surgery between 1998 to 2018 were reviewed. Clinicopathologic and treatment data were collected. Tumor tissues were subjected to light microscopy and IHC. RESULTS: Of 43 patients treated during the study period, 21 had archived tumor tissue available and were included. The median age at diagnosis was 47 years, and 13 patients (62%) were male. Thirteen patients (62%) had T2 disease, and none had nodal or distant metastasis at diagnosis. Tumors were positive for NICD1 expression in eight cases (38%), c-MYC expression in eight (38%), and P63 expression in 11 (52%). Positive NICD1 expression was associated with predominantly solid (vs. cribriform/tubular) pattern (P < 0.001), treatment with orbital exenteration (vs. eye-sparing surgery) (P = 0.008), local recurrence (P = 0.047), and death (P = 0.012). Negative P63 expression was associated with predominantly solid pattern (P = 0.001), local recurrence (P = 0.012), distant metastasis (P = 0.001), and death (P = 0.035). A higher percentage of tumor cells staining for c-MYC was associated with presence of perineural invasion (P = 0.036). Positive NICD1 expression was associated with worse disease-free survival (hazard ratio, 6.27; 95% CI, 1.29-30.46), whereas positive P63 expression was associated with better disease-free survival (hazard ratio, 0.03; 95% CI, 0.0002-0.26). CONCLUSIONS: IHC for NICD1 and P63 should be considered in lacrimal gland ACC because of their prognostic value and potential as treatment targets.
引用
- Zhao J, Williams MD, Hernandez M, et al. Prognostic Impact of Notch1 Intracellular Domain, P63, and c-MYC in Lacrimal Gland Adenoid Cystic Carcinoma. Invest Ophthalmol Vis Sci. 2024. PMID: 39230995. doi:10.1167/iovs.65.11.4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。